This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  88R6140 JTZ-D
 
  By: Hall S.B. No. 514
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to investigations and disciplinary action by the Texas
  Medical Board regarding certain treatments or practices during the
  COVID-19 pandemic.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  (a) This Act applies to any person engaged in a
  profession regulated by the Texas Medical Board who was
  investigated or subject to disciplinary action by the board for:
               (1)  prescribing or advocating for the use of
  ivermectin, hydroxychloroquine, or budesonide in the prevention or
  treatment of COVID-19;
               (2)  making statements regarding the efficacy of masks
  in preventing the transmission of COVID-19; or
               (3)  failing to wear or require others to wear masks
  intended to prevent the transmission of COVID-19 in connection with
  the person's practice, other than in areas where it was customary to
  wear masks before the COVID-19 pandemic.
         (b)  Not later than December 1, 2023, the Texas Medical Board
  shall, for any person described by Subsection (a) of this section:
               (1)  vacate any disciplinary action imposed;
               (2)  expunge all records of the board related to the
  investigation and disciplinary action;
               (3)  refund all fines collected from the person; and
               (4)  reimburse the person for all legal fees incurred
  as a result of the investigation or disciplinary action.
         SECTION 2.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2023.